Literature DB >> 22130607

First chemical feature-based pharmacophore modeling of potent retinoidal retinoic acid metabolism blocking agents (RAMBAs): identification of novel RAMBA scaffolds.

Puranik Purushottamachar1, Jyoti B Patel, Lalji K Gediya, Omoshile O Clement, Vincent C O Njar.   

Abstract

The first three-dimensional (3D) pharmacophore model was developed for potent retinoidal retinoic acid metabolism blocking agents (RAMBAs) with IC(50) values ranging from 0.0009 to 5.84nM. The seven common chemical features in these RAMBAs as deduced by the Catalyst/HipHop program include five hydrophobic groups (hydrophobes), and two hydrogen bond acceptors. Using the pharmacophore model as a 3D search query against NCI and Maybridge conformational Catalyst formatted databases; we retrieved several compounds with different structures (scaffolds) as hits. Twenty-one retrieved hits were tested for RAMBA activity at 100nM concentration. The most potent of these compounds, NCI10308597 and HTS01914 showed inhibitory potencies less (54.7% and 53.2%, respectively, at 100nM) than those of our best previously reported RAMBAs VN/12-1 and VN/14-1 (90% and 86%, respectively, at 100nM). Docking studies using a CYP26A1 homology model revealed that our most potent RAMBAs showed similar binding to the one observed for a series of RAMBAs reported previously by others. Our data shows the potential of our pharmacophore model in identifying structurally diverse and potent RAMBAs. Further refinement of the model and searches of other robust databases is currently in progress with a view to identifying and optimizing new leads.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130607      PMCID: PMC3259215          DOI: 10.1016/j.ejmech.2011.11.010

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  50 in total

1.  Identification of the retinoic acid-inducible all-trans-retinoic acid 4-hydroxylase.

Authors:  J A White; Y D Guo; K Baetz; B Beckett-Jones; J Bonasoro; K E Hsu; F J Dilworth; G Jones; M Petkovich
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

2.  Identification of common functional configurations among molecules.

Authors:  D Barnum; J Greene; A Smellie; P Sprague
Journal:  J Chem Inf Comput Sci       Date:  1996 May-Jun

3.  Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells.

Authors:  W Wouters; J van Dun; A Dillen; M C Coene; W Cools; R De Coster
Journal:  Cancer Res       Date:  1992-05-15       Impact factor: 12.701

4.  Highly specific cytochrome P450-like enzymes for all-trans-retinoic acid in T47D human breast cancer cells.

Authors:  I S Han; J H Choi
Journal:  J Clin Endocrinol Metab       Date:  1996-06       Impact factor: 5.958

5.  Autoinduction of retinoic acid metabolism to polar derivatives with decreased biological activity in retinoic acid-sensitive, but not in retinoic acid-resistant human breast cancer cells.

Authors:  B M van der Leede; C E van den Brink; W W Pijnappel; E Sonneveld; P T van der Saag; B van der Burg
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

Review 6.  Retinoids in cancer chemoprevention.

Authors:  R Lotan
Journal:  FASEB J       Date:  1996-07       Impact factor: 5.191

7.  Phase I evaluation of all-trans-retinoic acid in adults with solid tumors.

Authors:  J S Lee; R A Newman; S M Lippman; M H Huber; T Minor; M N Raber; I H Krakoff; W K Hong
Journal:  J Clin Oncol       Date:  1993-05       Impact factor: 44.544

8.  Elevated plasma lipid peroxide content correlates with rapid plasma clearance of all-trans-retinoic acid in patients with advanced cancer.

Authors:  J F Muindi; H I Scher; J R Rigas; R P Warrell; C W Young
Journal:  Cancer Res       Date:  1994-04-15       Impact factor: 12.701

9.  Analysis of the oxidative catabolism of retinoic acid in rat Dunning R3327G prostate tumors.

Authors:  M D Krekels; J Zimmerman; B Janssens; R Van Ginckel; W Cools; C Van Hove; M C Coene; W Wouters
Journal:  Prostate       Date:  1996-07       Impact factor: 4.104

10.  Induction of the oxidative catabolism of retinoid acid in MCF-7 cells.

Authors:  M D Krekels; A Verhoeven; J van Dun; W Cools; C Van Hove; L Dillen; M C Coene; W Wouters
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  6 in total

Review 1.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

2.  Retinol Depletion in COVID-19.

Authors:  Aziz Rodan Sarohan; Hakan Akelma; Eşref Araç; Özgür Aslan; Osman Cen
Journal:  Clin Nutr Open Sci       Date:  2022-05-28

3.  Comparison of the ligand binding site of CYP2C8 with CYP26A1 and CYP26B1: a structural basis for the identification of new inhibitors of the retinoic acid hydroxylases.

Authors:  Robert S Foti; Philippe Diaz; Dominique Douguet
Journal:  J Enzyme Inhib Med Chem       Date:  2016-07-17       Impact factor: 5.051

Review 4.  Retinoic Acid and Its Derivatives in Skin.

Authors:  Łukasz Szymański; Rafał Skopek; Małgorzata Palusińska; Tino Schenk; Sven Stengel; Sławomir Lewicki; Leszek Kraj; Paweł Kamiński; Arthur Zelent
Journal:  Cells       Date:  2020-12-11       Impact factor: 6.600

5.  Computational Investigation Identified Potential Chemical Scaffolds for Heparanase as Anticancer Therapeutics.

Authors:  Shraddha Parate; Vikas Kumar; Jong Chan Hong; Keun Woo Lee
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

6.  Establishment of a screening protocol for identification of aminopeptidase N inhibitors.

Authors:  Miaomiao Niu; Fengzhen Wang; Fang Li; Yaru Dong; Yueqing Gu
Journal:  J Taiwan Inst Chem Eng       Date:  2014-12-31       Impact factor: 5.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.